Substituted 6-(2-hydroxybenzylamino)purine derivatives, their use as medicaments and compositions containing these derivatives

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989592%3A15310%2F17%3A73582772" target="_blank" >RIV/61989592:15310/17:73582772 - isvavai.cz</a>

Result on the web

<a href="https://worldwide.espacenet.com/publicationDetails/originalDocument?FT=D&date=20170301&DB=EPODOC&locale=en_EP&CC=EP&NR=2438068B1&KC=B1&ND=4#" target="_blank" >https://worldwide.espacenet.com/publicationDetails/originalDocument?FT=D&date=20170301&DB=EPODOC&locale=en_EP&CC=EP&NR=2438068B1&KC=B1&ND=4#</a>

DOI - Digital Object Identifier

—

Result language

angličtina

Original language name

Substituted 6-(2-hydroxybenzylamino)purine derivatives, their use as medicaments and compositions containing these derivatives

Original language description

The invention relates to the preparation of substituted 6-(2-hydroxybenzylamino)purine derivatives, their use as medicaments and compositions containing these derivatives.

Czech name

—

Czech description

—

Type

P - Patent

CEP classification

—

OECD FORD branch

10401 - Organic chemistry

Project

<a href="/en/project/GA301%2F08%2F1649" target="_blank" >GA301/08/1649: Modulation of cell division of normal and cancer cells by cyclin-dependent kinase inhibitors</a><br>

Continuities

P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Publication year

2017

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Patent/design ID

2438068

Publisher

EPO_1 -

Publisher name

European Patent Office

Place of publication

Munich, The Hague, Berlin, Vienna, Brussels

Publication country

—

Date of acceptance

Mar 1, 2017

Owner name

Univerzita Palackého v Olomouci, Biopatterns s.r.o.

Method of use

A - Výsledek využívá pouze poskytovatel

Usage type

A - K využití výsledku jiným subjektem je vždy nutné nabytí licence